The Epidemiological Signal Points to Prevention, Not Treatment Real-world data from over 1 million patients with type 2 diabetes consistently shows that semaglutide users have 40-70% lower risk of first-time Alzheimers diagnosis compared to other diabetes medications
All references to glutathione pertain exclusively to in vitro and preclinical laboratory applications
A positive surprise is that the approval was for a tablet formulation, which is less expensive to manufacture than the capsule versions studied by Lilly during clinical trials, David Risinger, a senior managing director and senior research analyst covering diversified biopharmaceuticals at Leerink Partners, shared in a research note
Madsen KA, Garber AK, Mietus-Snyder ML, Valente JK, Tran CT, Wlasiuk L, Matos RI, Neuhaus J, Lustig RH: A lifestyle intervention for pediatric obesity: efficacy and behavioral and biochemical predictors of response